Rising Houston health care tower secures $50M in donations

fresh funding

The tower, set for completion in 2026, will be the new home of the School of Medicine and the School of Health Professions. Rendering courtesy of SLAM Architecture

Houston’s Baylor College of Medicine has received more than $50 million in donations for construction of the Lillie and Roy Cullen Tower.

The tower, originally announced last year and set for completion in 2026, will be the new home of the School of Medicine and the School of Health Professions.

The new contributions are:

  • $25 million from The Brown Foundation.
  • $16 million from The DeBakey Medical Foundation, adding to $12 million that already was pledged.
  • $10 million from the Sarofim Foundation, matching a previous $10 million commitment from the late Fayez Sarofim.

“Thanks to tremendous support from the community, we have raised almost $150 million in philanthropy for the new state-of-the-art home for the School of Medicine and School of Health Professions. Cullen Tower isn’t just an investment in infrastructure, but an investment in the health and well-being of future generations,” Dr. Paul Klotman, president, CEO, and executive dean at the Baylor College of Medicine, says in a news release.

The 503,000-square-foot Lillie and Roy Cullen Tower is the first phase of Baylor’s planned Health Sciences Park, an 800,000-square-foot project that will combine medical education and research at a site next to Baylor Medicine and Baylor St. Luke’s Medical Center.

In recognition of The DeBakey Medical Foundation’s increased commitment to Cullen Tower and additional funding for the Michael E. DeBakey Department of Surgery, the Baylor College of Medicine will name the park the Michael E. DeBakey Health Sciences Park. It will encompass the new Cullen Tower, another research tower to be built in the future, a building that links the two towers, and the existing Jamail Specialty Care Center.

“The comprehensive scope of the park — combining spaces for education, research, and clinical care — is a fitting tribute to Dr. DeBakey’s contributions to Baylor and the field of health care. The Cullen Tower embodies his legacy of excellence, which will inspire further generations of Baylor students to strive for greatness while advancing medical knowledge and providing compassionate care to patients,” says Dr. H. David Short III, president of the DeBakey foundation.

When seven Houston Public Libraries were damaged during Hurricane Harvey, the library system rolled out its resources to the communities that needed it most. Photo courtesy of Houston Public Library Foundation

Innovative library on wheels brings tech lab and resources to Houston communities that need it most

rolling out

To those that think the Houston Public Library has a dearth of innovation, think again.

"If people don't think libraries are relevant, they just need to visit one," says Sally Swanson, executive director of the Houston Public Library Foundation. "The 21st century library really is a technology hub.

"The libraries here in Houston have been around over a hundred years, but regardless of what decade it was in, it has always kept up with the needs of the community, therefore it always has to be innovative."

In the aftermath of Hurricane Harvey, seven libraries across Houston were forced to close due to extreme flood damage. To mitigate the loss, the HPL decided to modernize its Mobile Express Unit, a custom-built technology lab and library on wheels designed to bring access to technology and programs to high-need neighborhoods.

"Even though the hurricane was two years ago, the damage in Houston was so extensive, that only one of those seven locations has reopened," says Swanson. "The other ones are still in need, so having the Mobile Express now will bridge that gap until the city is able to reconstruct or reopen those closed locations.

"Thanks to the renovated Mobile Express, we'll be able to go to community centers, to schools and to other events. Basically, we're bringing the library to the people."

With the help of The Brown Foundation Inc., John P. McGovern Foundation, The Powell Foundation, corporate partner Crown Castle and thousands of donations from generous Houstonians, the HPL will use the $325,000 vehicle outfitted with advanced programmatic features to expand services to a growing waiting list of neighborhoods in need.

"We couldn't have done this without the generosity of the Houston community," says Swanson. "The vehicle itself was $325,000 and there was another $30,000 added in for technology. I would really like to thank our significant donors that made this vehicle possible. Thanks to that outpouring of support, this is now our reality."

The Mobile Express Unit, which will begin venturing out and serving the community in early February, has three touchscreen monitors, one desktop tower, 12 student Apple MacBook laptops and 10 iPads in a training room, eight tech lab workstations and a 3D printer.

"Even though we've had the public debut, it hasn't started accepting appointments yet," says Swanson. "The Mobile Express is operated through the Houston Public Library's Community Engagement division. They will have the online schedule and they have a driver and a program team that will go out and bring activities to people. The beauty of this is that it's free to the public."

As a fun way to get the word out, the HPL is sponsoring a contest for kids to name the Mobile Express Unit's robot mascot. Kids that enter the vehicle will be able to use the mascot to learn robotics and whoever wins the naming contest will receive that same robot, with five runners up receiving five slightly smaller versions of the robot.

"The beauty of the Mobile Express is its versatility," says Swanson. "There is a need for getting kids engaged in STEM activities and while some kids are very computer proficient, there are others that don't have access to the equipment. There will be learning at every stage and kids will be able to go on the vehicle, experiment with the different platforms and be part of the technology.

"There will be computer classes, coding classes and 3D printing workshops, so anyone, no matter their level of skills will be able to go on and actually have a real positive hands-on experience."

The Mobile Express, which can serve up to 24 participants or expand its interior walls to accommodate more, has an outdoor flat screen for dance sessions or for showing the instruction that is being held on the inside.

With its improved classroom flow and comfortable and engaging environment, the Mobile Express is able to offer English as a Second Language classes, workforce development classes, sewing workshops and pop-up library activities.

The mobile library and technology lab on wheels has no restrictions on its service area, so it can go into every neighborhood and corner of Houston and serve the public where it is needed the most.

"Every stop the Mobile Express makes is a continued investment into the Houston community," says Swanson. "A lot of people take for granted that everyone has equal access to online resources, but there's a lot of families that are having trouble making ends meet and they don't have internet in their home.

"The Houston Public Library has always been really good about finding creative and innovative ways of bringing services to the community."

For those that can't wait to make an appointment with the Mobile Express, there's always the neighborhood brick-and-mortar library.

"I welcome everyone in Houston to just go visit their local library," says Swanson. "They will be very surprised when they walk in and they see how many people are there reading or on computer terminals. They'll also be surprised by the library's focus on technology."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston digital health platform Koda lands strategic investment

money moves

Houston-based advance care planning platform Koda Health has added another investor to the lineup.

The company secured a strategic investment for an undisclosed amount from UPMC Enterprises, the commercialization arm of the University of Pittsburgh Medical Center. The funding is part of Koda's oversubscribed series A funding round that closed in October, according to a release.

"UPMC Enterprises’ investment is a meaningful signal, not just to Koda, but to the broader market," Dr. Desh Mohan, chief medical officer and co-founder of Koda Health, said in the news release. "It validates that health systems are ready to invest in infrastructure that makes advance care planning work the way it should: proactively, at scale, and with the human support that these conversations require. Having UPMC Enterprises as a strategic investor puts us in a unique position to prove what's possible."

Koda has raised $14 million to date, according to a representative from the company. Its series A round was led by Evidenced, with participation from Mudita Venture Partners, Techstars and the Texas Medical Center last year. At the time, the company said the funding would allow it to scale operations and expand engineering, clinical strategy and customer success. The company described the round as a "pivotal moment," as it had secured investments from influential leaders in the healthcare and venture capital space.

Koda Health, which was born out of the TMC's Biodesign Fellowship in 2020, saw major growth last year, as well, and now supports more than 1 million patients nationwide through partnerships with Cigna Healthcare, Privia Health, Guidehealth, Sentara, UPMC and Memorial Hermann Health System.

The company integrated its end-of-life care planning platform with Dallas-based Guidehealth in April 2025 and with Epic Systems in July 2025. It also won the 2025 Houston Innovation Award in the Health Tech Business category. Read more here.

UH med school gets $2M gift and more top Houston innovation news

Trending Topics

Editor's note: The top Houston innovation news of the month is full of fresh funding, with two Texas medical schools receiving major gifts — one of historic proportions. Below are the five most-read InnovationMap headlines from April 16-30, 2026.

UH med school granted $2M gift to offer student scholarships

A new scholarship endowment aims to support students in the University of Houston’s recently established medical school. The University of Houston’s Tilman J. Fertitta Family College of Medicine received a planned estate gift commitment estimated at $2.1 million to establish the Bob Diehl and Teresa Evans Diehl Scholarship Endowment. The scholarship will assist full-time medical students who demonstrate financial need and meet academic standards. Continue reading.

How Houston innovators played a role in the historic Artemis II splashdown

Research from Rice University played a critical role in the safe return of U.S. astronauts aboard NASA’s Artemis II mission this month. Rice mechanical engineer Tayfun E. Tezduyar and longtime collaborator Kenji Takizawa developed a key computational parachute fluid-structure interaction (FSI) analysis system that proved vital in NASA’s Orion capsule’s descent into the Pacific Ocean. The FSI system, originally developed in 2013 alongside NASA Johnson Space Center, was critical in Orion’s three-parachute design, which slowed the capsule as it returned to Earth, according to Rice. Continue reading.

Baylor scientist lands $2M grant to explore links between viruses and Alzheimer’s

A Baylor College of Medicine scientist will begin exploring the possible link between Alzheimer’s disease and viral infections thanks to a $2 million grant awarded in March. Dr. Ryan S. Dhindsa hypothesizes that Alzheimer’s may have some link to previous viral infections contracted by the patient. To study this intriguing possibility, the American Brain Foundation has gifted him the Cure One, Cure Many award in neuroinflammation. Continue reading.

New UT Austin med center, anchored by MD Anderson, gets historic gift

A donation announced April 21 breaks a major record at the University of Texas at Austin. Michael and Susan Dell are now UT Austin's first supporters to give $1 billion. In response, the university will create the UT Dell Campus for Advanced Research and the UT Dell Medical Center to "advance human health," per a press release. Continue reading.

Houston VC funding surged nearly 50% in Q1 2026, report says

Houston saw a jump in VC funding in Q1 2026, fueled by several major investments in clean energy startups. Image via Getty Images

First-quarter venture capital funding for Houston-area startups climbed nearly 50 percent compared to the same time last year, according to the PitchBook-NVCA Venture Monitor. In Q1 2026, Houston-area startups raised $532.3 million, a 49 percent jump from $320.2 million in Q1 2025, according to the PitchBook-NVCA Venture Monitor. However, the Q1 total fell 23 percent from the $671.05 million raised in Q4 2025. Continue reading.

New 'living pharmacy' biotech company launches out of Rice venture studio

fighting cancer

Rice University’s biotech venture studio RBL LLC has launched a new “living pharmacy” company, Duracyte, designed to make cancer treatment easier on patients.

Backed by an up to $45 million Advanced Research Projects Agency for Health (ARPA-H) award, Duracyte aims to commercialize implantable biohybrid pharmacy devices that are designed to produce therapeutic proteins inside the human body around the clock, replacing the need for regular injections and infusions for some cancer patients.

The company’s main platform is its Hybrid Advanced Molecular Manufacturing Regulator (HAMMR), a rechargeable, implantable device that can sense biological signals, monitor tumor environments and adjust therapeutic output in real time. HAMMR has wireless communication capabilities, which allow patients and clinicians to remotely monitor results through an app every five minutes and make changes to treatment plans without a hosptial visit. Additionally, the device can generate its own oxygen supply, which is key for the therapeutic cells’ survival.

“Biologic medicines such as monoclonal antibodies, cytokines and metabolic regulators already account for a significant share of modern therapeutics, but the way we deliver them today often requires frequent injections or infusions that can be demanding for patients and lead to inconsistent drug levels,” Daniel Anderson, MIT professor and co-founder of Duracyte, said in a news release. “Our vision is to enable a continuous, stable therapy by producing these medicines directly inside the body, which could improve treatment consistency, reduce side effects and ultimately transform how biologic therapies are delivered across many diseases.”

Duracyte’s first clinical trial is slated to begin by the end of 2026 and will focus on recurrent ovarian cancer. The Phase I study will build upon existing work on encapsulated cytokine pharmacy technology, and the company hopes that within a few years this treatment can reach clinical application.

The development of Duracyte is supported by ARPA-H's Targeted Hybrid Oncotherapeutic Regulation (THOR) project, which supports a multidisciplinary research consortium co-led by Omid Veiseh, a professor of bioengineering at Rice. The consortium also includes others at Rice, The University of Texas MD Anderson Cancer Center, Stanford University, Carnegie Mellon University, Northwestern University and the University of Houston, plus industry collaborators like Chicago-based CellTrans.

“What we are building is the culmination of years of progress in cell engineering, biomaterials and implantable device technology,” Veiseh added in the release. “By combining these advances with real-time sensing and adaptive drug delivery, we are working with the support of RBL to create a true ‘living pharmacy’ that can deliver continuous, precisely controlled biologic therapies and fundamentally change how these treatments reach patients.”

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. Duracyte is the third company launched by RBL, including Sentinel BioTherapeutics, a clinical-stage immunotherapy company developing localized cytokine therapies for solid tumors, and SteerBio, a regenerative medicine company targeting lymphedema.

“Duracyte exemplifies the kind of breakthrough that Houston’s ecosystem is built to produce,” Paul Wotton, managing partner of RBL LLC and co-founder of Duracyte, added in the release. “With world-class clinical infrastructure, exceptional engineering talent and initiatives like the Texas Biotech Task Force driving alignment across industry, investment and talent, this region is uniquely positioned to move the most ambitious ideas in medicine from concept to patient, faster than anywhere else.”

View All Listings